June 2, 2017

Novel Molecular Imaging Technologies

Hello! My name is Katie Parkins and I am a PhD candidate in the Department of Medical Biophysics at Western University. I work in the Imaging Research Laboratories at Robarts Research Institute under the co-supervision of Drs. Paula Foster and John Ronald.

My research involves using novel molecular imaging technologies to study concomitant tumour resistance (CTR): the ability of the primary tumour to inhibit the growth of secondary metastases. Tumor cell dormancy and recurrence are important clinical problems for breast cancer patients and their physicians as secondary metastases can develop many years after successful removal of the primary tumour and adjuvant therapy. We expect this research will produce important information about what influences metastatic tumour growth and possibly advance therapeutic development for breast cancer patients.

I have been fortunate to have many opportunities presenting my work at both international and regional conferences. My first author manuscript was published in the Nature Publishing Group journal, Scientific Reports, and recently recognized at the 2017 London Health Research Day as a recipient of the Lucille and Norton Wolf Publication Award. It’s very encouraging to see the interest in my work and the excitement for new results to come!

Thank you to BCSC for your trainee support!

– Katie Parkins, PhD Candidate

Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Health Sciences Centre

Breast Cancer Canada and REAL Canadian Breast Cancer Alliance Establish National Recommendations for Breast Cancer

For the first time in Canada, the country’s leading breast cancer experts have come together to establish national standards for breast cancer. This suite of

Remembering Dr. Juliet Daniel

Dr. Juliet Daniel’s passing from metastatic breast cancer is a profound loss to science, to McMaster University, to the Caribbean and Canadian communities that shaped

Inaugural BCC–CSSO Career Development Research Award Presented to Dr. Matthew Castelo

Breast Cancer Canada (BCC) and the Canadian Society of Surgical Oncology (CSSO) are proud to announce the inaugural BCC-CSSO Career Development Research Award, a $200,000

Meet the Researcher: Urvi Patel

Urvi Patel is a PhD student in the Department of Anatomy & Cell Biology at Western University. She is conducting BCC-funded breast cancer research under

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.